As of January 2026, more than 70,000 patients were already being treated with Mounjaro in France without reimbursement, illustrating the scale of suppressed demand now set to be released
This study provides one of the largest real-world descriptions to date of how adults with overweight or obesity use and switch GLP-1RAs over time, said first author Luyu (Amber) Xie, Ph.D., Pharm.D., Assistant Professor in the Peter ODonnell Jr
+1.2 kg, respectively)
Through dietary modifications, exercise, and nutrition companion products like Mitopure, individuals can safeguard their muscle and skin health, ensuring a more balanced approach to weight loss and overall well-being
Mounjaro is an FDA-approved diabetes drug for adults with type 2 diabetes
They own their own drug delivery platform and partners with major pharma companies, but they are not focused on the lucrative and rapidly growing GLP-1 space